PMI CFO Emmanuel Babeau Discusses Strong Growth at Investor Conference

PMI by 2FIRSTS.ai

Dec.06.2023

PMI CFO Emmanuel Babeau Discusses Strong Growth at Investor Conference

PMI CFO Emmanuel Babeau expects strong organic revenue growth and double-digit EPS growth by 2023, driven by the growing strength of their smoke-free product portfolio.

According to an official announcement on the website of Philip Morris International (PMI), Emmanuel Babeau, the Chief Financial Officer of PMI, addressed investors at the Morgan Stanley Global Consumer and Retail Conference held in New York on November 5th.

Baba expressed its anticipation of achieving remarkable organic revenue growth in 2023. Diluted earnings per share, adjusted for currency neutrality, are expected to witness a double-digit increase. "This is supported by the sustained strength of our smoke-free product portfolio, especially the two heavyweight brands, IQOS and ZYN," said Baba.

References:

[1] Philip Morris International Inc. Presents at 2023 Morgan Stanley Global Consumer & Retail Conference

Also Read:

[1] BAT and PMI Collaborate to Produce Cigarettes in Switzerland

[2] PMI introduces IQOS ILUMA in Morocco

[3] PMI Launches IQOS ILUMA in Emerging Markets

#North America #United States #PMI #Heated tobacco products

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Urges South Africa to Differentiate Smoke-Free Products from Cigarettes

South Africa is drafting new tobacco legislation aimed at reducing smoking-related deaths and promoting harm reduction.PMI said smoke-free products such as nicotine pouches and heated devices could play a critical role in reducing harm. Patrik Hildingsson, PMI’s director for oral products communications, said South Africa is developing a new regulatory framework to recognise and regulate smoke-free products, calling it a “big change” for the industry.

Oct.22 by 2FIRSTS.ai

Hanwha Securities: KT&G's Global Market Share Expected to Hit New High, Overseas Heated Tobacco Sales Projected to Grow 74%

KT&G predicted to reach all-time high global market share in 2025, with Q3 sales expected to surge 10%.

Oct.16 by 2FIRSTS.ai

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Mexico Passes Law Banning Commercial Sale and Advertising of Vapes and E-Cigarettes

Mexico’s Chamber of Deputies approved a constitutional reform prohibiting the production, import, export, transport, distribution, sale, and advertising of vapes and e-cigarettes nationwide. The law does not ban personal use of such products. Backed by President Claudia Sheinbaum, the amendment to the General Health Law imposes penalties of one to eight years in prison and fines between 11,314 and 226,280 pesos (approximately USD 621–12,430).